Q1 2018 13F Holders as of 31 Mar 2018
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
95,963,102
-
Total 13F shares
-
48,941,898
-
Share change
-
+7,150,590
-
Total reported value
-
$2,495,515,451
-
Put/Call ratio
-
948%
-
Price per share
-
$50.99
-
Number of holders
-
159
-
Value change
-
+$366,583,930
-
Number of buys
-
93
-
Number of sells
-
55
Institutional Holders of Ultragenyx Pharmaceutical Inc. - COMMON STOCK (RARE) as of Q1 2018
As of 31 Mar 2018 Ultragenyx Pharmaceutical Inc. - COMMON STOCK (RARE) had 159 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 48,941,898 shares of stock of the company.
Largest 10 holders included WELLINGTON MANAGEMENT GROUP LLP, Capital Research Global Investors, BlackRock Inc., VANGUARD GROUP INC, FMR LLC, Capital International Investors, PRICE T ROWE ASSOCIATES INC /MD/, STATE STREET CORP, FEDERATED INVESTORS INC /PA/, and AMERIPRISE FINANCIAL INC.
This table shows 159 institutional shareholders of the security as of 31 Mar 2018.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.